Animal testing and its alternatives—the most important omics is economics
Open accessThe DOI matches its Crossref record; 61 of the 62 references it cites were found in a registry or an index.
Abstract
For a long time, the discussion about animal testing vs its alternatives centered on animal welfare. This was a static warfare, or at least a gridlock, where life scientists had to take a position and make their value choices and hardly anyone changed sides. Technical advances have changed the frontline somewhat, with in vitro and in silico methods gaining more ground. Only more recently has the economic view begun to have an impact: Many animal tests are simply too costly, take too long, and give misleading results. As an extension and update to previous articles in this series written a decade ago, we reanalyze the economic landscape of especially regulatory use of animal testing and this time also consider respective alternative tests. Despite some ambiguity and data gaps, which we have filled with crude estimates, a picture emerges of globally regulated industries that are subject to stark geographic and sectorial differences in regulation, which determine their corresponding animal use. Both animal testing and its alternatives are industries in their own right, offering remarkable business opportunities for biotech and IT companies as well as contract research organizations. In light of recent revelations as to the reproducibility and relevance issues of many animal tests, the economic consequences of incorrect results and the reasons for still maintaining often outdated animal test approaches are discussed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“the average cost of a single, 2-generation reproductive animal toxicity study worldwide is €318,295 and for Europe alone is €285,842 (45), or roughly $349,890 and $314,215, respectively.”
From Limitations of Animal Studies for Predicting Toxicity in Clinical Trials (2019) · cites this paper as [45]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Using a database of more than 800,000 animal toxicity studies performed for 350 chemicals under rigorous guidelines, a reviewer found toxicity was repeatable just 70% of the time in the same species (45).”
From Limitations of Animal Studies for Predicting Toxicity in Clinical Trials (2019) · cites this paper as [45]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Compared with the costs of in vitro testing, animal tests range from 1.5× to >30× as expensive (44,45).”
From Limitations of Animal Studies for Predicting Toxicity in Clinical Trials (2019) · cites this paper as [45]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Can the pharmaceutical industry reduce attrition rates?
Kola, I., & Landis, J. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1470 · Cited by 4,167
Clinical development success rates for investigational drugs
Hay, M., Thomas, D. W., Craighead, J. L., Economides, C., & Rosenthal, J. (2014) · Nature Biotechnology · doi:10.1038/nbt.2786 · Cited by 2,536
Diagnosing the decline in pharmaceutical R&D efficiency
Scannell, J. W., Blanckley, A., Boldon, H., & Warrington, B. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3681 · Cited by 1,981
Four hundred and sixty brands of e-cigarettes and counting: implications for product regulation
Zhu, S.-H., Sun, J. Y., Bonnevie, E., Cummins, S. E., Gamst, A., Yin, L., & Lee, M. (2014) · Tobacco Control · doi:10.1136/tobaccocontrol-2014-051670 · Cited by 913
Trends in Risks Associated With New Drug Development: Success Rates for Investigational Drugs
DiMasi, J. A., Feldman, L., Seckler, A., & Wilson, A. (2010) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2009.295 · Cited by 845
Toxicology for the twenty-first century
Hartung, T. (2009) · Nature · doi:10.1038/460208a · Cited by 661
Farsalinos, K. E., & Polosa, R. (2014) · Therapeutic Advances in Drug Safety · doi:10.1177/2042098614524430 · Cited by 594
Alternative (non-animal) methods for cosmetics testing: current status and future prospects—2010
Adler, S., Basketter, D., Creton, S., Pelkonen, O., van Benthem, J., Zuang, V., Andersen, K. E., Angers-Loustau, A., Aptula, A., Bal-Price, A., et al. (2011) · Archives of Toxicology · doi:10.1007/s00204-011-0693-2 · Cited by 584
Screening Chemicals for Estrogen Receptor Bioactivity Using a Computational Model
Browne, P., Judson, R. S., Casey, W. M., Kleinstreuer, N. C., & Thomas, R. S. (2015) · Environmental Science & Technology · doi:10.1021/acs.est.5b02641 · Cited by 276
Research works printed but not linked: 2
- Bottini, A. A., Alepee, N., De Silva, O. et al. (2008). Optimi- zation of the post-validation process. The report and recom- mendations of ECVAM workshop 67. Altern Lab Anim 36, 353-366.
- nrd3681 · DOI · Paper page
Cited by
Limitations of Animal Studies for Predicting Toxicity in Clinical Trials
Van Norman, G. A. (2019) · JACC: Basic to Translational Science · doi:10.1016/j.jacbts.2019.10.008 · Cited by 732
“Using a database of more than 800,000 animal toxicity studies performed for 350 chemicals under rigorous guidelines, a reviewer found toxicity was repeatable just 70% of the time in the same species (45).”
BackgroundIngber, D. E. (2020) · Advanced Science · doi:10.1002/advs.202002030 · Cited by 277
Fedi, A., Vitale, C., Ponschin, G., Ayehunie, S., Fato, M., & Scaglione, S. (2021) · Journal of Controlled Release · doi:10.1016/j.jconrel.2021.05.028 · Cited by 229
Avoiding Regrettable Substitutions: Green Toxicology for Sustainable Chemistry
Maertens, A., Golden, E., & Härtung, T. (2021) · ACS Sustainable Chemistry & Engineering · doi:10.1021/acssuschemeng.0c09435 · Cited by 163
Innovative Human Three-Dimensional Tissue-Engineered Models as an Alternative to Animal Testing
Bédard, P., Gauvin, S., Ferland, K., Caneparo, C., Pellerin, È., Chabaud, S., & Bolduc, S. (2020) · Bioengineering · doi:10.3390/bioengineering7030115 · Cited by 158
Jeong, J., & Choi, J. (2022) · Environmental Science & Technology · doi:10.1021/acs.est.1c07413 · Cited by 158
NMR as a “Gold Standard” Method in Drug Design and Discovery
Emwas, A.-H. M., Szczepski, K., Poulson, B. G., Chandra, K., McKay, R. T., Dhahri, M., Alahmari, F., Jaremko, Ł., Lachowicz, J. I., & Jaremko, M. (2020) · Molecules · doi:10.3390/molecules25204597 · Cited by 155
Probabilistic risk assessment – the keystone for the future of toxicology
Maertens, A., Golden, E., Luechtefeld, T. H., Hoffmann, S., Tsaioun, K., & Hartung, T. (2022) · ALTEX · doi:10.14573/altex.2201081 · Cited by 126
Animal-derived products in science and current alternatives
Duarte, A. C., Costa, E. C., Filipe, H. A. L., Saraiva, S. M., Jacinto, T., Miguel, S. P., Ribeiro, M. P., & Coutinho, P. (2023) · Biomaterials Advances · doi:10.1016/j.bioadv.2023.213428 · Cited by 117
The (misleading) role of animal models in drug development
Härtung, T. (2024) · Frontiers in Drug Discovery · doi:10.3389/fddsv.2024.1355044 · Cited by 116
Härtung, T. (2023) · ALTEX · doi:10.14573/altex.2309191 · Cited by 110
Modeling the Human Body on Microfluidic Chips
Jalili-Firoozinezhad, S., Miranda, C. C., & Cabral, J. M. S. (2021) · Trends in Biotechnology · doi:10.1016/j.tibtech.2021.01.004 · Cited by 101
The new paradigm in animal testing – “3Rs alternatives”
Poh, W. T., & Stanslas, J. (2024) · Regulatory Toxicology and Pharmacology · doi:10.1016/j.yrtph.2024.105705 · Cited by 100
Pred-Skin: A Web Portal for Accurate Prediction of Human Skin Sensitizers
Borba, J. V. V. B., Braga, R. C., Alves, V. M., Muratov, E. N., Kleinstreuer, N., Tropsha, A., & Andrade, C. H. (2020) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.0c00186 · Cited by 93
Replacing Animal Testing with Stem Cell-Organoids : Advantages and Limitations
Park, G., Rim, Y. A., Sohn, Y., Nam, Y., & Ju, J. H. (2024) · Stem Cell Reviews and Reports · doi:10.1007/s12015-024-10723-5 · Cited by 92
Strategies to apply 3Rs in preclinical testing
Gorzalczany, S. B., & Basso, A. (2021) · Pharmacology Research & Perspectives · doi:10.1002/prp2.863 · Cited by 91
Beyond the 3Rs: Expanding the use of human-relevant replacement methods in biomedical research
Herrmann, K. (2019) · ALTEX · doi:10.14573/altex.1907031 · Cited by 87
Paparella, M., Bennekou, S. H., & Bal-Price, A. (2020) · Reproductive Toxicology · doi:10.1016/j.reprotox.2020.08.002 · Cited by 80
Stem Cells for Next Level Toxicity Testing in the 21st Century
Fritsche, E., Haarmann‐Stemmann, T., Kapr, J., Galanjuk, S., Hartmann, J., Mertens, P. R., Kämpfer, A. A. M., Schins, R. P. F., Tigges, J., & Koch, K. (2021) · Small · doi:10.1002/smll.202006252 · Cited by 75
Toward good in vitro reporting standards
Hartung, T. (2019) · ALTEX · doi:10.14573/altex.1812191 · Cited by 65
“Along with our mantra “the most important omics is economics” (Meigs et al., 2018), this has also to be seen as an economic problem.”
BackgroundCiallella, H. L., Russo, D. P., Aleksunes, L. M., Grimm, F. A., & Zhu, H. (2020) · Laboratory Investigation · doi:10.1038/s41374-020-00477-2 · Cited by 64
Silva, R. J., & Tamburic, S. (2022) · Cosmetics · doi:10.3390/cosmetics9050090 · Cited by 63
“The 3Rs principle of replacement, reduction, and refinement, introduced by Russel and Burch [4], was reduced to a single R approach (replacement), making the cosmetics industry a major propellant of innovation in the field of alternative testing methods [5,6].”
BackgroundPapantoniou, I., Hall, G. N., Loverdou, N., Lesage, R., Herpelinck, T., Mendes, L. F., & Geris, L. (2020) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.11.012 · Cited by 63
Ciallella, H. L., Russo, D. P., Aleksunes, L. M., Grimm, F. A., & Zhu, H. (2021) · Environmental Science & Technology · doi:10.1021/acs.est.1c02656 · Cited by 63
Tumor Microenvironment and Hydrogel-Based 3D Cancer Models for In Vitro Testing Immunotherapies
Vitale, C., Marzagalli, M., Scaglione, S., Dondero, A., Bottino, C., & Castriconi, R. (2022) · Cancers · doi:10.3390/cancers14041013 · Cited by 62
Rivero, M. N., Lenze, M., Izaguirre, M., Damonte, S. H. P., Aguilar, A. J., Wikinski, S., & Gutiérrez, M. L. (2021) · Food and Chemical Toxicology · doi:10.1016/j.fct.2021.112229 · Cited by 60
Ching, T., Toh, Y., Hashimoto, M., & Zhang, Y. S. (2021) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2021.05.007 · Cited by 60
Chunduri, V., & Maddi, S. (2022) · ADMET & DMPK · doi:10.5599/admet.1513 · Cited by 59
Chung, E., Russo, D. P., Ciallella, H. L., Wang, Y., Wu, M., Aleksunes, L. M., & Zhu, H. (2023) · Environmental Science & Technology · doi:10.1021/acs.est.3c00648 · Cited by 57
New European Union statistics on laboratory animal use – what really counts!
Busquet, F., Kleensang, A., Rovida, C., Herrmann, K., Leist, M., & Hartung, T. (2020) · ALTEX · doi:10.14573/altex.2003241 · Cited by 54
Advancing human health risk assessment
Lanzoni, A., Castoldi, A. F., Kass, G. E. N., Terron, A., Seze, G. D., Bal‐Price, A., Bois, F. Y., Delclos, K. B., Doerge, D. R., Fritsche, E., et al. (2019) · EFSA Journal · doi:10.2903/j.efsa.2019.e170712 · Cited by 53
Synthetic and Biogenic Materials for Oral Delivery of Biologics: From Bench to Bedside
Ding, S., Alexander, E., Liang, H., Kulchar, R. J., SINGH, R. K., Herzog, R. W., Daniell, H., & Leong, K. W. (2025) · Chemical Reviews · doi:10.1021/acs.chemrev.4c00482 · Cited by 51
Krebs, A., van Vugt-Lussenburg, B. M. A., Waldmann, T., Albrecht, W., Boei, J., ter Braak, B., Brajnik, M., Braunbeck, T., Brecklinghaus, T., Busquet, F., et al. (2020) · Archives of Toxicology · doi:10.1007/s00204-020-02802-6 · Cited by 48
Biosensors to Monitor Cell Activity in 3D Hydrogel-Based Tissue Models
Fedi, A., Vitale, C., Giannoni, P., Caluori, G., & Marrella, A. (2022) · Sensors · doi:10.3390/s22041517 · Cited by 48
Heart-on-a-chip systems: disease modeling and drug screening applications
Butler, D., & Reyes, D. R. (2024) · Lab on a Chip · doi:10.1039/d3lc00829k · Cited by 47
Ciallella, H. L., Russo, D. P., Sharma, S., Li, Y., Sloter, E. D., Sweet, L., Huang, H., & Zhu, H. (2022) · Environmental Science & Technology · doi:10.1021/acs.est.2c01040 · Cited by 47
Pun, S., Prakash, A., Demaree, D., Krummel, D. P., Sciumè, G., Sengupta, S., & Barrile, R. (2024) · Advanced Healthcare Materials · doi:10.1002/adhm.202401876 · Cited by 46
Taylor, K., & Alvarez, L. R. (2019) · Computational Toxicology · doi:10.1016/j.comtox.2019.100112 · Cited by 45
Frankowski, J., Kurzątkowska, M., Sobczak, M., & Piotrowska, U. (2023) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2023.123313 · Cited by 44
A call for a Human Exposome Project
Härtung, T. (2023) · ALTEX · doi:10.14573/altex.2301061 · Cited by 44
Romeo, D., Hischier, R., Nowack, B., Jolliet, O., Fantke, P., & Wick, P. (2022) · Environmental Science Nano · doi:10.1039/d1en01014j · Cited by 42
Busquet, F., Härtung, T., Pallocca, G., Rovida, C., & Leist, M. (2020) · Archives of Toxicology · doi:10.1007/s00204-020-02787-2 · Cited by 42
Progress and promise of alternative animal and non-animal methods in biomedical research
Freires, I. A., Colón, D. F., Soares, L. F. F., Costa, I. S., de Araújo, L. P., Breseghello, I., Abdalla, H. B., Lazarini, J. G., Rosalen, P. L., Pigossi, S. C., et al. (2023) · Archives of Toxicology · doi:10.1007/s00204-023-03532-1 · Cited by 41
Härtung, T. (2021) · ALTEX · doi:10.14573/altex.2101051 · Cited by 41
Brazil Moves Toward the Replacement of Animal Experimentation
de Ávila, R. I., & Valadares, M. C. (2019) · Alternatives to Laboratory Animals · doi:10.1177/0261192919856806 · Cited by 39
Ram, R., Gadaleta, D., & Allen, T. E. H. (2022) · Computational Toxicology · doi:10.1016/j.comtox.2022.100232 · Cited by 39
Romero, J. C., Berlinicke, C. A., Chow, S., Duan, Y., Wang, Y., Chamling, X., & Smirnova, L. (2023) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2022.1094291 · Cited by 39
Integrating 3Rs approaches in WHO guidelines for the batch release testing of biologicals
Lilley, E. J., Isbrucker, R. A., Ragan, I., & Holmes, A. M. (2021) · Biologicals · doi:10.1016/j.biologicals.2021.10.002 · Cited by 38
REACH out-numbered! The future of REACH and animal numbers
Rovida, C., Busquet, F., Leist, M., & Hartung, T. (2023) · ALTEX · doi:10.14573/altex.2307121 · Cited by 37
The validation of regulatory test methods – Conceptual, ethical, and philosophical foundations
Härtung, T. (2024) · ALTEX · doi:10.14573/altex.2409271 · Cited by 36
Recent Options and Techniques to Assess Improved Bioavailability: In Vitro and Ex Vivo Methods
Józsa, L., Nemes, D., Pető, Á., Kósa, D., Révész, R., Bácskay, I., Haimhoffer, Á., & Vasvári, G. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15041146 · Cited by 35
Sillé, F. C. M., Busquet, F., Fitzpatrick, S., Herrmann, K., Leenhouts-Martin, L., Luechtefeld, T., Maertens, A., Miller, G. W., Smirnova, L., Tsaioun, K., et al. (2024) · ALTEX · doi:10.14573/altex.2407081 · Cited by 35
Expanding CAR-T cell immunotherapy horizons through microfluidics
Kim, H., Kim, S., Lim, H., & Chung, A. J. (2024) · Lab on a Chip · doi:10.1039/d3lc00622k · Cited by 34
Maertens, A., Luechtefeld, T. H., Knight, J., & Härtung, T. (2024) · ALTEX · doi:10.14573/altex.2312291 · Cited by 35
The state of the scientific revolution in toxicology
Härtung, T., & Tsatsakis, A. M. (2021) · ALTEX · doi:10.14573/altex.2106101 · Cited by 34
Călina, D. C., Hernández, A. F., Härtung, T., Egorov, A. M., Izotov, B. N., Νikolouzakis, Τ. Κ., Tsatsakis, A. M., Vlachoyiannopoulos, P. G., & Docea, A. O. (2021) · Life · doi:10.3390/life11090907 · Cited by 31
E-validation – Unleashing AI for validation
Härtung, T., Maertens, A., & Luechtefeld, T. H. (2024) · ALTEX · doi:10.14573/altex.2409211 · Cited by 31
Kramer, N. I., Hoffmans, Y., Wu, S., Thiel, A., Thatcher, N., Allen, T. E. H., Levorato, S., Traussnig, H., Schulte, S., Boobis, A. R., et al. (2019) · Archives of Toxicology · doi:10.1007/s00204-019-02501-x · Cited by 31
Tackling Ischemic Reperfusion Injury With the Aid of Stem Cells and Tissue Engineering
Zamorano, M., Castillo, R. L., Beltrán, J. F., Herrera, L., Farias, J. A., Antileo, C., Aguilar-Gallardo, C., Pessoa, A., Calle, Y., & Farías, J. G. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2021.705256 · Cited by 30
Garcia‐Calvo, E., García-García, A., Madrid, R., Martín, R., & García, T. (2020) · Foods · doi:10.3390/foods10010066 · Cited by 30
(2024) · ALTEX · doi:10.14573/altex.2403281 · Cited by 28
“Economical aspects (Meigs et al., 2018) also need to be considered: Some DNT concerns are covered also in the two-generation study (TG 416), considered the most definitive study for developmental and reproductive toxicity (DART).”
BackgroundMethodGelMA hydrogel: A game-changer in 3D tumor modeling
Jiao, W., Shan, J., Gong, X., Sun, Y., Sang, L., Ding, X., Zhou, H., & Yu, M. (2024) · Materials Today Chemistry · doi:10.1016/j.mtchem.2024.102111 · Cited by 27
Eckstrum, K., Striz, A., Ferguson, M. S., Zhao, Y., & Sprando, R. L. (2022) · Food and Chemical Toxicology · doi:10.1016/j.fct.2022.112828 · Cited by 27
de Leeuw, V. C., van Oostrom, C. T. M., Wackers, P. F. K., Pennings, J. L. A., Hodemaekers, H. M., Piersma, A. H., & Hessel, E. V. S. (2022) · Chemosphere · doi:10.1016/j.chemosphere.2022.135298 · Cited by 26
Deep Learning in Environmental Toxicology: Current Progress and Open Challenges
Tan, H., Jin, J., Fang, C., Zhang, Y., Chang, B., Zhang, X., Yu, H., & Shi, W. F. (2023) · ACS ES&T Water · doi:10.1021/acsestwater.3c00152 · Cited by 26
New Worm on the Block: Planarians in (Neuro)Toxicology
Ireland, D., & Collins, E. S. (2022) · Current Protocols · doi:10.1002/cpz1.637 · Cited by 25
Seo, Y., Bang, S., Son, J., Kim, D., Jeong, Y., Kim, P., Yang, J.-H., Eom, J.-H., Choi, N., & Kim, H. N. (2021) · Bioactive Materials · doi:10.1016/j.bioactmat.2021.11.009 · Cited by 24
Applications of Engineered Skin Tissue for Cosmetic Component and Toxicology Detection
Wang, M., Zhang, L., Hao, H., Yan, M., & Zhu, Z. (2024) · Cell Transplantation · doi:10.1177/09636897241235464 · Cited by 23
(3D) Bioprinting—Next Dimension of the Pharmaceutical Sector
Mihaylova, A., Shopova, D., Parahuleva, N., Yaneva, A., & Bakova, D. R. (2024) · Pharmaceuticals · doi:10.3390/ph17060797 · Cited by 23
Methodologies for Generating Brain Organoids to Model Viral Pathogenesis in the CNS
Hopkins, H. K., Traverse, E. M., & Barr, K. L. (2021) · Pathogens · doi:10.3390/pathogens10111510 · Cited by 23
Abarkan, F. Z., Wijen, A. M. A., van Eijden, R. M. G., Struijs, F., Dennis, P., Ritskes-Hoitinga, M. J., & Visseren-Hamakers, I. J. (2022) · Animals · doi:10.3390/ani12202757 · Cited by 22
Lohse, S., Wasmer, M. S., & Reydon, T. A. C. (2020) · Perspectives on Science · doi:10.1162/posc_a_00357 · Cited by 22
Engagement of scientists with the public and policymakers to promote alternative methods
von Aulock, S., Busquet, F., Locke, P. A., Herrmann, K., & Härtung, T. (2022) · ALTEX · doi:10.14573/altex.2209261 · Cited by 21
Lilley, E. J., Coppens, E., Das, P., Galaway, F., Isbrucker, R. A., Sheridan, S., Stickings, P., & Holmes, A. M. (2022) · Biologicals · doi:10.1016/j.biologicals.2022.11.002 · Cited by 20
Martorell, J. J. V., Mariscal, A. J. F., & Martínez, J. M. O. (2024) · Science & Education · doi:10.1007/s11191-024-00529-9 · Cited by 20
Nair, A. L., Mesch, L., Schulz, I., Becker, H., Raible, J., Kiessling, H., Werner, S., Rothbauer, U., Schmees, C., Busche, M., et al. (2021) · Biosensors · doi:10.3390/bios11090314 · Cited by 20
Méloni, M., Balzaretti, S., & Ceriotti, L. (2019) · Regulatory Toxicology and Pharmacology · doi:10.1016/j.yrtph.2019.04.022 · Cited by 20
Mathisen, G. H., Bearth, A., Jones, L. B., Hoffmann, S., Vist, G. E., Ames, H. M., Husøy, T., Svendsen, C., Tsaioun, K., Ashikaga, T., et al. (2024) · Archives of Toxicology · doi:10.1007/s00204-024-03802-6 · Cited by 20
Chen, D., Huang, H., Huang, Y., Yang, W., Shan, W., Hao, G., Wu, J., & Song, B. (2023) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.3c00410 · Cited by 19
60 Years of the 3Rs symposium: Lessons learned and the road ahead
Balls, M., Baß, R., Curren, R. D., helen, F. J., Goldberg, A. M., Härtung, T., Herrmann, K., Kleinstreuer, N., Libowitz, L. A., Parascandola, J., et al. (2024) · ALTEX · doi:10.14573/altex.2403061 · Cited by 19
Organotypic Models to Study Human Glioblastoma: Studying the Beast in Its Ecosystem
Pamies, D., Zurich, M., & Härtung, T. (2020) · iScience · doi:10.1016/j.isci.2020.101633 · Cited by 19
Trends in the use of animals and non-animal methods over the last 20 years
Taylor, K. (2024) · ALTEX · doi:10.14573/altex.2410111 · Cited by 18
Golden, E., Ukaegbu, D. C., Ranslow, P. B. D., Brown, R. H., Härtung, T., & Maertens, A. (2023) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.2c00383 · Cited by 17
Pesticide effect on earthworm lethality via interpretable machine learning
Kotli, M., Piir, G., & Maran, U. (2023) · Journal of Hazardous Materials · doi:10.1016/j.jhazmat.2023.132577 · Cited by 17
New approach methodologies: EU regulatory horizons
Edwards, M., Blanquie, O., Moriarty, O., Beken, S., & Ehmann, F. (2025) · Nature Reviews Drug Discovery · doi:10.1038/d41573-025-00053-7 · Cited by 17
Christodoulou, I., Goulielmaki, M., Kritikos, A., Zoumpourlis, P., Koliakos, G., & Zoumpourlis, V. C. (2022) · Cells · doi:10.3390/cells11071102 · Cited by 17
Proceedings of a workshop to address animal methods bias in scientific publishing
Krebs, C. E., Camp, C., Constantino, H., Courtot, L., Kavanagh, O., Leite, S. B., Madden, J., Paini, A., Poojary, B., Tripodi, I. J., et al. (2022) · ALTEX · doi:10.14573/altex.2210211 · Cited by 17
Herculano, R. D., Mussagy, C. U., Guerra, N. B., Brasil, G. S. P., Floriano, J. F., Burd, B. S., Su, Y., Sasaki, J. C. D. S., Chagas, P. A. M., Scontri, M., et al. (2023) · Biomaterials Advances · doi:10.1016/j.bioadv.2023.213739 · Cited by 15
Assessing Agricultural Toxicity in Brazil: Advances and Opportunities in the 21st Century
da Silva, A. C. G., Sousa, I. P., dos Santos, T. R. M., & Valadares, M. C. (2020) · Toxicological Sciences · doi:10.1093/toxsci/kfaa120 · Cited by 15
In Vitro Skin Models for Skin Sensitisation: Challenges and Future Directions
Losada-Fernández, I., Martín, A. S., Moreno-Nombela, S., Suárez‐Cabrera, L., Valencia, L., Pérez‐Aciego, P., & Velasco, D. (2025) · Cosmetics · doi:10.3390/cosmetics12040173 · Cited by 13
Real-Time, Continuous Monitoring of Tissue Chips as an Emerging Opportunity for Biosensing
Cognetti, J. S., & Miller, B. L. (2025) · Sensors · doi:10.3390/s25165153 · Cited by 14
Sinenko, I. L., Turnell‐Ritson, R. C., Munier, F. L., & Dyson, P. J. (2023) · Experimental Eye Research · doi:10.1016/j.exer.2023.109447 · Cited by 13
Confronting the bias towards animal experimentation (animal methods bias)
Krebs, C. E., & Herrmann, K. (2024) · Frontiers in Drug Discovery · doi:10.3389/fddsv.2024.1347798 · Cited by 13
Kasteel, E. E. J., & Westerink, R. H. S. (2021) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1080/17425255.2021.1885647 · Cited by 13
Green Toxicology: Making Chemicals Benign by Design
Maertens, A. (2022) · RSC green chemistry series · doi:10.1039/9781839164392 · Cited by 12
Wilhelmi, P., Giri, V., Zickgraf, F. M., Haake, V., Henkes, S., Driemert, P., Michaelis, P., Busch, W., Scholz, S., Flick, B., et al. (2023) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2023.110565 · Cited by 13
Lilley, E. J., Bruysters, M. W. P., Das, P., Gill, S., Isbrucker, R. A., Jones, D., & Holmes, A. M. (2023) · Biologicals · doi:10.1016/j.biologicals.2023.101721 · Cited by 12
Classification of Developmental Toxicants in a Human iPSC Transcriptomics-Based Test
Cherianidou, A., Seidel, F., Kappenberg, F., Dreser, N., Blum, J. H., Waldmann, T., Blüthgen, N., Meisig, J., Madjar, K., Henry, M., et al. (2022) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.1c00392 · Cited by 12
Parvatam, S., Bharadwaj, S., Radha, V., & Rao, M. (2020) · Journal of Biosciences · doi:10.1007/s12038-020-00112-8 · Cited by 12
Dierichs, N., Piersma, A. H., Peeters, R. P., Visser, W. E., Meima, M. E., & Hessel, E. V. S. (2025) · Critical Reviews in Toxicology · doi:10.1080/10408444.2025.2461076 · Cited by 11
Metadata
- Authors
- Meigs, L.
- Affiliations
- Johns Hopkins University (US)
- Corresponding author
- Meigs, Lucy
- Venue
- ALTEX
- Publisher
- ALTEX Edition
- Published
- 2018
- Volume
- 35
- Issue
- 3
- Pages
- 275-305
- ISSN
- 0946-7785 (ISSN-L)
- 1868-596X
- OpenAlex
- W2883962615
- Cited by
- 184
- References
- 62
- Citations by year
- 2026: 15 · 2025: 22 · 2024: 32 · 2023: 30 · 2022: 31 · 2021: 25 · 2020: 20 · 2019: 8
- FWCI
- 19.39
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- Locations
- ALTEX (publishedVersion, cc-by)
- PubMed (publishedVersion)
- KOPS (University of Konstanz) (submittedVersion, cc-by)
- Topics
- Health Sciences › Veterinary › Small Animals › Animal testing and alternatives
- Health Sciences › Nursing › Issues, ethics and legal aspects › Biomedical Ethics and Regulation
- Social Sciences › Law › Animal Law and Welfare
- Keywords
- animal experimentation, alternatives to animal testing, in vitro methods, in silico analysis, contract research organizations, biotechnology industry
- MeSH terms
- Animals, Animal Testing Alternatives, Animal Welfare, Humans, Research, Reproducibility of Results, Toxicity Tests, Models, Animal
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.